U.S. Industrial REITs Stock News

Verrica Pharmaceuticals (VRCA) opened Q1 2026 with revenue of about US$5.0 million and a basic EPS loss of US$0.45, while trailing twelve month figures show revenue of US$37.2 million and a basic EPS loss of US$1.31. Over the past year, the company reported quarterly revenue moving from US$3.4 million in Q1 2025 to US$14.3 million in Q3 2025, then settling around the US$5.0 million mark in Q1 2026. EPS moved from a loss of US$1.03 to a small profit of US$0.02 in Q2 2025 before returning to...

Gilat Satellite Networks (NasdaqGS:GILT) opened 2026 with Q1 revenue of US$110.5 million and basic EPS of US$0.07. This set the tone for how its growth story is feeding through to the bottom line. The company reported revenue of US$92.0 million and an EPS loss of US$0.11 in Q1 2025, compared to revenue of US$110.5 million and an EPS profit of US$0.07 in Q1 2026. Trailing 12 month EPS is US$0.50 on revenue of US$470.1 million, which points to earnings growth supported by wider net margins. For...

a.k.a. Brands Holding (AKA) has opened 2026 with Q1 revenue of US$132.5 million and a reported loss of US$7.1 million, which translates to basic EPS of US$0.66 in the red. Over the past year, the company has seen trailing twelve month revenue sit at US$604.0 million with a loss of US$30.2 million, or basic EPS of US$2.81 in the red, setting a clear backdrop of continued unprofitability. For investors, the latest quarter keeps the spotlight firmly on margins and on whether the current profile...

Paysafe (PSFE) opened 2026 with Q1 revenue of US$442.7 million and a loss of US$36.5 million on a net income basis, which translated to basic EPS of a US$0.71 loss. Over the past five quarters, the company has seen revenue move from US$420.1 million in Q4 2024 to US$401 million in Q1 2025 and then to US$442.7 million in Q1 2026. Over the same period, basic EPS shifted from a profit of US$0.55 in Q4 2024 to losses of US$0.33 in Q1 2025 and US$0.71 in Q1 2026. For investors, the latest report...

Jack in the Box (JACK) opened Q2 2026 with total revenue of US$254.3 million and basic EPS of US$0.65, alongside net income excluding extra items of US$12.5 million, setting the tone for how its turnaround story is tracking. The company has seen quarterly revenue move between US$265.7 million and US$371.1 million over the past five reported periods, while basic EPS has ranged from US$0.30 to US$1.63. This gives investors a clear view of how earnings power has shifted through recent quarters...

Kornit Digital (NasdaqGS:KRNT) opened Q1 2026 with revenue of US$48.5 million and a basic EPS loss of US$0.19, alongside a quarterly net loss of US$8.2 million, setting a cautious tone for the latest update. Over recent periods the company has seen revenue move from US$60.7 million in Q4 2024 to US$58.9 million in Q4 2025 and then to US$48.5 million in Q1 2026. EPS has swung between a profit of US$0.05 and losses such as US$0.17 and US$0.19, which keeps the spotlight firmly on margin pressure...

Amentum Holdings (AMTM) has released its Q2 2026 results with revenue of US$3.5b and net income of US$54m, translating to basic EPS of US$0.22 for the quarter and trailing twelve month EPS of US$0.61. The company has seen quarterly revenue move between US$3.2b and US$3.9b over the past six reported periods, while quarterly basic EPS has ranged from US$0.02 to US$0.22. This sets up a picture of modest top line progress paired with gradually improving earnings power. For investors, the key...

Enanta Pharmaceuticals (ENTA) has just posted Q2 2026 results with revenue of US$17.2 million and a basic EPS loss of US$0.45, while trailing twelve month figures show revenue of US$69.2 million and a basic EPS loss of US$2.47. Over recent quarters the company has seen revenue move between US$14.9 million and US$18.6 million, with quarterly basic EPS losses ranging from roughly US$0.41 to US$1.06 and trailing twelve month net losses of US$62.0 million. For investors, the story this quarter is...

VEON (NasdaqGS:VEON) has opened 2026 with Q1 numbers that put the focus squarely on earnings quality, reporting US$1.2 billion in revenue and basic EPS of US$1.42, while trailing twelve month EPS sits at US$7.65 on revenue of US$4.6 billion. Over recent quarters the company has seen revenue move from US$998 million in Q4 2024 to US$1.03 billion in Q1 2025, US$1.09 billion in Q2 2025 and US$1.20 billion in Q1 2026, with quarterly EPS ranging from a loss of US$2.00 in Q3 2025 to US$8.50 in Q2...

QuickLogic (QUIK) opened Q1 2026 with revenue of about US$5.1 million and a basic EPS loss of US$0.13, setting the tone for another quarter where the top line and per share results remain firmly in focus for investors who track the stock through earnings season. Over the past year, the company has reported quarterly revenue in a range of roughly US$2.0 million to US$5.7 million, while basic EPS has ranged from a small profit of about US$0.01 per share to a quarterly loss of about US$0.24 per...

Perella Weinberg Partners recently reported first-quarter 2026 results showing net income of US$1.49 million, down sharply from US$17.34 million a year earlier, while also affirming a quarterly dividend of US$0.07 per Class A share payable in June. Alongside the weaker quarter, the firm expanded Chief Financial Officer Alexandra Gottschalk’s remit to include Chief Operating Officer, highlighting a tighter focus on operational execution as management cited longer timelines to complete complex...

Hasbro’s Q1 2026 earnings in focus Hasbro (HAS) opened 2026 with Q1 revenue of US$1,000.2 million and basic EPS of US$1.41, setting a clear snapshot of the business against a current share price of US$95.65. Over recent quarters the company has seen revenue move from US$887.1 million in Q1 2025 to US$1,000.2 million in Q1 2026, while basic EPS shifted from US$0.71 to US$1.41 over the same period. This gives investors a clearer look at how the top line and per share earnings are tracking. With...

Lineage Cell Therapeutics (LCTX) opened 2026 with Q1 revenue of US$1.7 million and a basic EPS loss of US$0.02, as net income excluding extraordinary items came in at a loss of US$4.8 million. The company has seen quarterly revenue move between US$1.5 million and US$6.6 million over the past year, while EPS has ranged from a loss of around US$0.13 per share to a small profit of US$0.00 per share, presenting a mixed picture regarding the path toward better margins. For investors, the latest...

Espey Mfg. & Electronics (ESP) has reported another solid set of Q3 2026 numbers, with revenue of about US$11.4 million and basic EPS of roughly US$1.03, supported by trailing 12 month EPS of US$3.95 on revenue of around US$42.2 million. The company has seen quarterly revenue range between US$9.1 million and US$13.6 million over the past six periods, while basic EPS has moved between US$0.66 and US$1.10. This sets up the latest quarter against a backdrop of higher trailing earnings growth and...

MaxCyte (NasdaqGS:MXCT) opened Q1 2026 with revenue of US$9.7 million and a basic EPS loss of US$0.04, while trailing 12 month figures show revenue of US$32.3 million and a basic EPS loss of US$0.37. The company has seen quarterly revenue move from US$10.4 million in Q1 2025 to US$9.7 million in Q1 2026, with net income moving from a loss of US$10.3 million to a loss of US$4.8 million over the same period. These figures frame the discussion for investors who are focused on how margins develop...

Costamare Bulkers Holdings (NYSE:CMDB) has opened 2026 with Q1 revenue of US$111.5 million, basic EPS of US$0.41 and net income of US$9.9 million, setting a clearer profit picture against a share price of US$19.02. The company has previously reported quarterly revenue figures ranging from US$222.9 million to US$318.9 million and a mix of positive and loss making EPS and net income results, so this quarter slots into a track record that already includes periods of pressure on earnings quality...

AI spending is no longer just a race to build the biggest models; it is increasingly about which companies can turn that investment into real earnings. With inflation pressures touching everything from fuel to freight, and central banks keeping rates higher for longer, cash generation and pricing power matter more than ever. The Profitable AI Stocks screener focuses on businesses already using AI to support profits rather than just promises. This article highlights 3 stocks from that list...

If you are wondering whether Consolidated Edison at around US$107 per share still offers fair value, you will want to see how different valuation methods line up on this stock. The share price has moved 0.7% over the last week, is down 4.1% over the last month, yet shows returns of 7.1% year to date, 8.5% over 1 year, 24.5% over 3 years and 62.7% over 5 years. This gives useful context before comparing price to fundamentals. Recent headlines have focused on Consolidated Edison in relation to...

Planet Labs PBC (NYSE:PL), through its German subsidiary, has secured a significant two-year contract with the Czech Republic's State Agricultural Intervention Fund. The agreement covers satellite imagery and AI-powered analytics to support agricultural monitoring and payments across the country. The contract is a multi-year, seven-figure national government deal that expands Planet Labs' role with European public sector agencies. Planet Labs PBC operates a fleet of Earth observation...

In May 2026, Principal Financial Group announced a new API integration with benefits administration platform Employee Navigator, allowing employees to complete evidence of insurability health questions directly within their initial benefits enrollment to streamline data sharing and speed up underwriting decisions for group benefits. This move highlights Principal’s push to simplify benefits administration for more than 90,000 small and midsize employer clients by reducing enrollment...

Nurix Therapeutics announced that CEO Arthur T. Sands will join fireside chats at major upcoming healthcare conferences and that updated efficacy and safety data for its oral BTK degrader bexobrutideg (NX-5948) in chronic lymphocytic leukemia will be presented in an oral session at the 2026 European Hematology Association Congress. The oral presentation slot and conference participation highlight growing scientific and investor attention on Nurix’s targeted protein degradation pipeline,...

Camtek (NasdaqGM:CAMT) sets the tone with Q1 2026 earnings Camtek (NasdaqGM:CAMT) opened 2026 with Q1 revenue of US$121.7 million and basic EPS of US$0.68, setting a clear marker for how the year is starting to shape up. The company has seen revenue move from US$117.3 million in Q4 2024 to US$128.1 million in Q4 2025, with basic EPS across those periods ranging from US$0.73 to US$0.78, while trailing 12 month EPS sits at US$1.05 on revenue of US$499.1 million. With a trailing net margin of...

Rising inflation worries, higher bond yields and choppy energy markets are putting pressure on weaker companies, especially those that rely heavily on cheap financing to survive. That environment can be harsh for most penny stocks, which often run out of cash before their plans get off the ground. The Elite Penny Stocks screener focuses only on companies with balance sheets that look better equipped to fund their ambitions. In this article, you will see 3 of the most interesting stocks from...

Paysign, Inc. reported past first-quarter 2026 results on May 12, posting revenue of US$28.04 million and net income of US$5.44 million, with diluted EPS of US$0.09 from continuing operations. The quarter marked a shift as patient affordability programs became Paysign’s largest revenue contributor, reflecting a mix change toward higher-margin pharma offerings. We’ll now examine how this record first quarter and the rise of patient affordability as Paysign’s largest revenue stream affect its...